STATINS AND GLAUCOMA
A large retrospective cohort study published in the British Journal of Ophthalmology suggests that long-term statin use may reduce both the risk of developing open-angle glaucoma (OAG) and the need for subsequent treatment escalation. Key Findings Reduced Incidence: Statin users showed a 15% lower risk of developing OAG at 5 years and a 10% lower risk at 10 years. Lower Risk of Treatment Escalation: Among patients with existing OAG (n = 29,598 per group), 5-year statin use was associated with: 60% lower risk of selective laser trabeculoplasty (SLT) 55% lower risk of minimally invasive glaucoma surgery (MIGS) 36% lower risk of traditional incisional glaucoma surgery 11% lower risk of needing additional topical ocular hypotensive prescriptions Sustained Benefit: These protective associations persisted through 10 years of follow-up, though the magnitude of effect slightly decreased over time. Potential Mechanisms & Limitations Researchers suggest statins may benef...